ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review

October 27, 1989

Uncertainty Lingers After NCI Meeting With Army; Activists Offer Advice

November 6, 1992

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

In Brief: Cancer Patient Said To Face Job Discrimination; A Goal Of New Epidemiology College: Certification

April 30, 1982

Funding Opportunities: Career Development Award In Leukemia

July 23, 1999